212-241-6984 ana.pereira@mssm.edu

Welcome to the Pereira Lab

Pereira Lab has been performing several studies to understand the neurobiology of age-related cognitive decline and Alzheimer’s disease using a translational approach. The lab’s major focus is on furthering knowledge of the mechanisms of selective vulnerability of glutamatergic neural circuits to synaptic changes in aging and neuronal loss in Alzheimer’s disease. Dr. Pereira and her lab members have been studying glutamatergic neuronal susceptibility with modern quantitative cell biology methods (at the synaptic and spine resolution with electron and confocal microscopy) in conjunction with molecular tools (next generation RNA sequencing, single cell sequencing, TRAP methodology) and functional assays in animal models and post-mortem Alzheimer’s brains. The lab uses a diverse set of methodological approaches to relate anatomical and molecular findings to functional changes.

Pereira Lab has also been investigating mechanisms by which chronic intermittent hypoxia, as it occurs in obstructive sleep apnea (OSA), can increase the risk and progression of Alzheimer’s disease. The laboratory seeks to explore molecular mechanisms underlying these susceptibilities in order to pinpoint novel therapeutic targets. As a physician-scientist, Dr. Pereira has been translating basic science findings from the laboratory into clinical studies and a trial of potential novel treatments for patients with Alzheimer’s disease.

Read More

Contact Us

Annenberg Building Room 20-02A
1468 Madison Avenue
New York, NY 10029

Phone: 212-241-6984
Email: ana.pereira@mssm.edu

Ana C. Pereira, MD, Associate Professor, Neurology and Neuroscience

Ana Pereira completed her Neurology Residency at Harvard University, with sub-specialty trainings in Cognitive Neurology at Columbia University, Post-Doctoral Research Fellowship at Columbia University and Translational and Clinical Investigation at Rockefeller University in New York City where she was an Assistant Professor of Clinical Investigation before moving to Mount Sinai. Clinically, Dr. Pereira evaluates patients at the Center for Cognitive Health at The Mount Sinai Hospital having expertise in diagnosing and treating neurodegenerative disorders and other cognitive syndromes.